Analysts Viewpoint
Keeping an Eye on Eton Pharmaceuticals Inc (ETON) After Insider Trading Activity
Eton Pharmaceuticals Inc’s filing revealed that its 10% Owner Opaleye Management Inc. acquired Company’s shares for reported $79814.0 on Oct
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.